TIBOTEC
Tibotec is a biopharmaceutical company focused on developing anti-viral treatments, with several promising compounds in development for the treatment of infectious diseases including HIV.
TIBOTEC
Social Links:
Industry:
Biotechnology Health Care Medical Device Pharmaceutical
Founded:
1994-01-01
Address:
Mechelen, Antwerpen, Belgium
Country:
Belgium
Website Url:
http://www.tibotec.com
Status:
Active
Similar Organizations
Britannia Pharmaceuticals
Britannia Pharmaceuticals focuses on innovative products for chronic and serious medical conditions, and treatment of Parkinson’s disease.
Densmore Pharmaceutical Laboratory
Densmore, a natural food supplement laboratory mainly specialising in ophthalmic solutions to treat eye diseases.
Dicot
Dicot is a pharmaceutical company focused on drug discovery and the development of novel lifestyle drugs to enrich patients' lives.
Fovea Pharmaceuticals
Fovea Pharmaceuticals is a French biopharmaceutical company that discovers and develops drugs for the treatment of ocular diseases.
Grace Therapeutics
Grace Therapeutics is a pharmaceutical company that focuses on drug delivery treatment for rare and orphan diseases.
Labtec
Labtec , a medium-size, German company, was founded in 1990 by Dr. Cordes. It considers some of the most innovative pharmaceutical
Roche France
Roche Diagnostics France is a biotechnology company that focuses on the research and development of pharmaceuticals and diagnostics.
SIDANIS
SIDANIS is a biopharmaceutical company specialized in developing drugs to prevent and treat infectious diseases in human & animal health.
Founder
Official Site Inspections
http://www.tibotec.com
- Host name: preprod.www.tibotec.com
- IP address: 148.177.18.161
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago
More informations about "Tibotec"
Tibotec Therapeutics Becomes Janssen Therapeutics, Part Of The …
Titusville, NJ, June 22, 2011 – Tibotec Therapeutics, Division of Centocor Ortho Biotech Products, L.P. announced that it has changed its name to Janssen Therapeutics, Division of Janssen …See details»
Tibotec - Crunchbase Company Profile & Funding
Tibotec is a biopharmaceutical company focused on developing anti-viral treatments, with several promising compounds in development for the treatment of infectious diseases including HIV. …See details»
Tibotec Virco Virology BV - Drug pipelines, Patents, Clinical trials ...
Explore Tibotec Virco Virology BV with its drug pipeline, therapeutic area, technology platform, 25 clinical trials, and 18 literature, Drug:R-91767, TMC-126, TMC-649128, Bedaquiline Fumarate, …See details»
Tibotec Virco NV - Drug pipelines, Patents, Clinical trials - Synapse
Explore Tibotec Virco NV with its drug pipeline, therapeutic area, technology platform, 2 literature, Disease Domain:Infectious Diseases, Immune System Diseases ...See details»
Tibotec - chemeurope.com
In 1995 Paul Stoffels (Janssen Pharmaceutica) joins Tibotec. The company was acquired by Johnson & Johnson in April 2002. The name of the company is derived from the tetrahydro …See details»
Tibotec - Products, Competitors, Financials, Employees, …
Tibotec develops life-saving anti-infective drugs. It focuses on research and development for the treatment of infectious diseases such as HIV, AIDS, and hepatitis C. The company was …See details»
Johnson & Johnson Acquires Tibotec-Virco | Johnson …
Johnson & Johnson acquired Tibotec-Virco to help address the vast unmet needs of people living with HIV/AIDS and other infectious diseases. Headquartered in Mechelen, Belgium, Tibotec-Virco applies the latest techniques in ultra-high …See details»
Tibotec Pharmaceuticals - Drug pipelines, Patents, Clinical trials ...
Explore Tibotec Pharmaceuticals with its drug pipeline, therapeutic area, technology platform, 19 clinical trials, 1 news, Drug:Simeprevir Sodium, Rilpivirine Hydrochloride. ... The statistics for …See details»
Unique Collaboration Between TB Alliance And Tibotec to …
Jun 16, 2009 [Seattle, WA] A new landmark collaboration between the Global Alliance for TB Drug Development (TB Alliance) a not-for-profit, product development partnership, and Tibotec …See details»
Tibotec - Tech Stack, Apps, Patents & Trademarks - Crunchbase
Tibotec is a pharmaceutical company with a focus on research and development for the treatment of infectious diseases such as HIV . Search Crunchbase. Start Free Trial . Chrome Extension. …See details»
Tibotec To Present Final Safety And Efficacy Results From Phase 2b ...
Nov 5, 2011 Tibotec is dedicated to the discovery and development of innovative HIV/AIDS and hepatitis C drugs, and anti-infectives for diseases of high unmet medical need. Contacts: …See details»
Tibotec - Contacts, Employees, Board Members, Advisors & Alumni
Tibotec is a pharmaceutical company with a focus on research and development for the treatment of infectious diseases such as HIV . Search Crunchbase. Start Free Trial . Chrome Extension. …See details»
New development in TB treatment - TB Alliance
Jun 17, 2009 Pharmaceutical giant Tibotec and the non-profit Global Alliance for TB Drug Development (TB Alliance) have teamed up to expedite the development of TMC207, which …See details»
Johnson & Johnson to Acquire Tibotec- Virco to Expand Portfolio …
Mar 26, 2003 Tibotec-Virco also has early stage research programs concentrating on the development of treatments for hepatitis C and other infectious diseases. In addition to its drug …See details»
Public–private partnership tackles TB challenges in parallel
In June, the Global Alliance for TB Drug Development (TB Alliance) and Tibotec, a subsidiary of Johnson & Johnson, announced a new partnership for parallel drug development of TMC-207.See details»
Tibotec Raises $36.5M Privately In Third Round For HIV Drugs
Dec 13, 2000 In addition, Tibotec signed a two-year agreement with Cerep SA, of Paris, in June 1999, also for screening potential anti-HIV agents in the French drug discovery company's …See details»
Unique Collaboration Between TB Alliance And Tibotec to …
Jun 17, 2009 Unique Collaboration Between TB Alliance And Tibotec to Accelerate Tuberculosis Drug Development Collaboration will focus on the development of TMC207 and the discovery …See details»
Tibotec Pharmaceuticals Submits New Drug Application for ...
Jul 26, 2010 Tibotec is dedicated to the discovery and development of innovative HIV/AIDS drugs and anti-infectives for diseases of high unmet medical need. About Tibotec TherapeuticsSee details»
Tobotec Signs Multiple Agreements With Generic Manufacturers …
Tibotec Pharmaceuticals today announced that it has granted multiple non-exclusive licenses to generic manufacturers including Hetero Drugs Limited, Matrix Laboratories Limited (a Mylan …See details»